1st Feb 2008 15:26
Alizyme PLC01 February 2008 For Immediate Release 1 February 2008 ALIZYME PLC TR - 1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existingshares to which voting rights are attached: Alizyme plc 2. Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights 3. Full name of person(s) subject to the notification obligation: The Royal Bank of Scotland Group plc 4. Full name of shareholder(s) (if different from 3.) ABN AMRO Bank N.V. 5. Date of the transaction and date on which the threshold is crossed orreached: 29/01/2008 6. Date on which issuer notified: 01/02/2008 7. Threshold(s) that is/are crossed or reached: 4% 8. Notified details: A: Voting rights attached to shares Class/type of Situation previous to the Resulting situation after the triggering transactionshares Triggering transaction Number of Number of Number of Number of voting rights % of voting rightsif possible using Shares Voting sharesthe ISIN CODE Rights Direct Direct Indirect Direct IndirectOrdinary Shares 9,350,000 9,350,000 8,000,000 8,000,000 3.98% GB 2p GB0000374289 B: Financial Instruments Resulting situation after the triggering transactionType of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument that may be acquired if rights Period/Date the instrument is exercised/ converted. Total (A+B) Number of voting rights % of voting rights8,000,000 3.98% 9. Chain of controlled undertakings through which the voting rights and/orthe financial instruments are effectively held, if applicable: The Royal Bank of Scotland Group plc (3.98%) RFS Holdings N.V. (3.98%) ABN AMRO Holding N.V. (3.98%) ABN AMRO Bank N.V. (3.98%) Proxy Voting: 10. Name of the proxy holder: n/a 11. Number of voting rights proxy holder will cease to hold: n/a 12. Date on which proxy holder will cease to hold voting rights: n/a 13. Additional information: This Notification is based upon the Voting Rights figure of 201,065,334 obtainedfrom your Regulatory Announcement dated 3rd December 2007 14. Contact name: David Campbell, Finance Director 15. Contact telephone number: + 44 (0) 1223 896000 For further information, please contact: David Campbell, Finance DirectorALIZYME plc Tel No: + 44 (0) 1223 896000 Further information on Alizyme can be found on the Company's website: www.alizyme.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
RBS.L